PAR 8.51% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-15

  1. 592 Posts.
    lightbulb Created with Sketch. 134
    I noted that also - no mention of any "Business Development". Whereas in the last quarterly they said, "Discussions are ongoing with a number of potential partners".

    So, either things have dried up abd we have nothing going on until P3 gets approved, or they have something lined up and will meet June 30 deadline, even if a $10mn upfront MPS deal. I'm thinking it is the former but one can only live in hope.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
0.020(8.51%)
Mkt cap ! $89.19M
Open High Low Value Volume
23.5¢ 25.5¢ 23.5¢ $161.2K 660.2K

Buyers (Bids)

No. Vol. Price($)
3 77422 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 15109 1
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.